Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses female pattern hair loss, the most common cause of hair loss in women, highlighting medical treatments like oral antiandrogens and topical minoxidil but reports no new clinical results.

Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.

This study found that 62% of premenopausal women with female pattern hair loss showed some improvement after 12 months of treatment with finasteride and an oral contraceptive, with no adverse reactions reported.

This article discusses treatments for female-pattern hair loss, such as topical minoxidil and antiandrogens like spironolactone, and reports no new clinical results.

This article reviews female pattern hair loss in women, highlighting its characteristics, treatment options, and the need to differentiate it from other hair loss conditions, and reports no new clinical results.

Female pattern hair loss in women is caused by hormones and genetics, leading to hair thinning, with various treatments available.

This review discusses female pattern hair loss, suggesting it involves both androgen-dependent and independent factors, but it reports no new clinical results.

This article reviews various treatment options for androgenetic alopecia, like finasteride, camouflage agents, and surgical methods, emphasizing patient education about each approach's limitations, but reports no new clinical results.

This study found that public perceptions and treatment choices for androgenic alopecia are heavily influenced by digital platforms, highlighting age and gender differences in preferences and behaviors.

This case study observed that an integrated treatment combining homeopathy and bioengineered hair therapy led to significant improvements in hair density, reduced hair fall, and emotional well-being for a woman with androgenetic alopecia.

In this study, the authors highlighted treatments for androgenetic alopecia, noting that combination therapies with drugs like minoxidil and antiandrogens often require at least 6 months for clinical improvement, while also emphasizing the value of patient counseling for informed treatment choices.

This study found that a once-daily capsule of minoxidil and spironolactone may safely reduce hair loss severity in women with female pattern hair loss.

This review describes the typical presentation of female pattern hair loss, noting that it often involves diffuse thinning on the scalp's top and crown without leading to total hair loss.

This paper discusses how studying hair follicles in the balding scalp could reveal fundamental biological processes, without reporting new experimental findings.

This study found that 42% of healthy men aged 18-49 in a community setting experienced moderate to extensive male pattern hair loss.

In this study, researchers found that women with Type 2 Diabetes Mellitus and hair loss had significantly lower levels of ferritin, zinc, and vitamin D compared to men, and constructed a validated risk score to predict severe nutrient deficiencies in these patients.

This study observed that non-scarring diffuse hair loss was common in systemic lupus erythematosus patients, but did not find a significant relationship with the SLE Disease Activity Index.

This commentary explores the challenges and considerations in treating female pattern hair loss, with no new clinical findings reported.